IM downregulates the expression of GLUT-1 and the glycolytic pathway components hexokinase 2, pyruvate kinase M2, and lactate dehydrogenase in IM-sensitive GIST cell lines. The gene discussed is SLC2A1; the disease is gastrointestinal stromal tumor.